In Silico, In Vitro Approach Against Synthesised Bromotriazepineone Derivatives

A class of heterocyclic chemical compounds known as bromotriazepinones has not yet had much research done on its pharmacological properties. Diverse techniques are known in the literature for the synthesis of derivatives of triazepinones. The biological interest in the triazepinone class of chemicals extends beyond synthesis to include a range of illnesses, including cancer (Bahule BB, Kalaskar SB, Yadav RP, Purohit AA, Int J Adv Res 5:708–715, 2017; Singh K, Mathela C, Indian J Chem Sect B Org Med Chem, 53:907–912, 2014), HIV (Subramaniam S, Sangeetha D, Res J Pharmacogn Phytochem, 9(3):173–176, 2017), and cardiovascular problems (Deepika G, Gopinath P, Kranthi G, Nagamani C, Jayasree YV, Naidu NV, Enaganti S, J Pharm Res, 5:1105–1107, 2012; Bano M, Barot KP, Jain SV, Ghate MD, Med Chem Res, 24:3008–3020, 2015). Condensed triazepines containing heterocycles were shown to have antioxidant, immunomodulatory, renal vasodilator, and sali-diuretic properties (Wadhwa P, Molecular docking study of novel covid-19 protease with current clinical management agents; LigPrep, Version 2.3, 2009; Impact, Version 5.5, 2005). Additionally, derivatives of fused triazepines containing a bridgehead nitrogen atom have intriguing biological characteristics (Schrödinger Suite, 2009), thus creating novel techniques for assembling these functionalised. A significant area of synthetic chemistry is the study of derivatives of bromotrizepinones. The development and modification of different kinds of heterocyclic compounds using multicomponent reactions as an effective technique method is a practical way to prepare a variety of products with specific substitutes (Glide, Version 5.5, 2009; Jain AN, Curr Protein PeptSci 7:407–420, 2006). Because of this, research into new protocols that employ a multicomponent strategy is becoming more and more active in the hopes of producing polysubstituted nitrogen scaffolds with biological activity for drug discovery initiatives such as the bromotriazepinone derivative, whose anti-skin cancer properties were investigated both in vitro and in silico.